(NOW) Stock Price prediction 4D Molecular Therapeutics Inc in 2030
Updated Stock Price 4D Molecular Therapeutics Inc plc (4D Molecular Therapeutics Inc)
You are interested in stocks 4D Molecular Therapeutics Inc plc and you would like to buy it, and maybe you already have it in your portfolio? If so, on this page you will find helpful information about the dynamics of the share price 4D Molecular Therapeutics Inc in 2030 How much will the share be worth 4D Molecular Therapeutics Inc in 2030?
Stock historical and prediction chart 4D Molecular Therapeutics Inc
The chart below shows the historical price fluctuation of the stock 4D Molecular Therapeutics Inc and a prediction chart for the next month. For simplicity, costs are divided into colors. Prediction prices include an optimistic prediction, a pessimistic prediction and a weighted average of the best prediction. Detailed share price values 4D Molecular Therapeutics Inc can be found in the table below.
4D Molecular Therapeutics Inc monthly stock prediction for 2030
| Data | Target | Opt. | Pes. | Vol. % |
|---|---|---|---|---|
| Jan | 25.2151 | 25.7122 | 24.7313 | 3.97% |
| Feb | 24.75 | 25.0457 | 24.4742 | 2.34% |
| Mar | 24.7944 | 25.1184 | 24.4527 | 2.72% |
| Apr | 25.1938 | 25.5622 | 24.6745 | 3.6% |
| May | 24.8018 | 25.1507 | 24.4197 | 2.99% |
| Jun | 24.9216 | 25.2323 | 24.5399 | 2.82% |
| Jul | 25.7471 | 26.1954 | 25.29 | 3.58% |
| Aug | 25.9379 | 26.3018 | 25.4408 | 3.38% |
| Sep | 25.7718 | 26.1074 | 25.3964 | 2.8% |
| Oct | 26.5174 | 27.0056 | 26.0558 | 3.65% |
| Fox | 26.0788 | 26.3745 | 25.7665 | 2.36% |
| Dec | 26.4294 | 26.7978 | 25.9279 | 3.36% |
Prediction 4D Molecular Therapeutics Inc for this year
Stock predict 4D Molecular Therapeutics Inc for 01-2030.
Uptrend prediction for this month with optimal price target at $25.2151.
Pessimistic: $24.7313.
Optimistic: $25.7122.
Stock predict 4D Molecular Therapeutics Inc for 02-2030.
Uptrend prediction for this month with optimal price target at $24.75.
Pessimistic: $24.4742.
Optimistic: $25.0457.
Stock predict 4D Molecular Therapeutics Inc for 03-2030.
Uptrend prediction for this month with optimal price target at $24.7944.
Pessimistic: $24.4527.
Optimistic: $25.1184.
Stock predict 4D Molecular Therapeutics Inc for 04-2030.
Uptrend prediction for this month with optimal price target at $25.1938.
Pessimistic: $24.6745.
Optimistic: $25.5622.
Stock predict 4D Molecular Therapeutics Inc for 05-2030.
Uptrend prediction for this month with optimal price target at $24.8018.
Pessimistic: $24.4197.
Optimistic: $25.1507.
Info
When to take profits on stocks 4D Molecular Therapeutics Inc? When to take a loss on stocks 4D Molecular Therapeutics Inc? What are analyst prediction for the stock 4D Molecular Therapeutics Inc? What does the future hold for stocks 4D Molecular Therapeutics Inc?
We predict stock results 4D Molecular Therapeutics Inc using neural networks based on historical data about shares 4D Molecular Therapeutics Inc. In addition, the Prediction uses technical analysis tools and takes into account geopolitical factors and news from around the world.
The goal is to find an investment strategy that will provide above-average returns in all market conditions. Our predict FDMT is updated daily to help investors know whether now is a good time to buy or sell stocks FDMT.
Stock prediction results 4D Molecular Therapeutics Inc are presented in the form of charts, tables and text information divided into time intervals.
The final prices of instruments at the close of the previous trading day are a signal to revise the stock prediction 4D Molecular Therapeutics Inc. It happens once a day.
Statement
All prediction data on the website is provided for informational purposes for the use of neural predicting tools in the financial market and does not constitute a solicitation for trading, nor is it a trading signal. By using prediction data, the investor assumes all financial risk. The EURUSD.site website is not responsible for the loss of your money on the stock exchange as a result of using the information contained on the website.